NASDAQ false 0001183765 0001183765 2024-01-11 2024-01-11

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): January 11, 2024

 

 

Molecular Templates, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-32979   94-3409596

(State or other jurisdiction of

incorporation or organization)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

9301 Amberglen Blvd, Suite 100

Austin, Texas 78729

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (512) 869-1555

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

   

Trading

symbol(s)

   

Name of each exchange

on which registered

Common Stock, $0.001 par value per share    MTEM    The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 11, 2024, Jonathan Lanfear notified the Board of Directors (the “Board”) of Molecular Templates, Inc. (the “Company”) of his decision to resign from the Board and as a member of the Board’s Audit Committee, effective as of January 11, 2024. Mr. Lanfear’s decision to resign was not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

Effective as of Mr. Lanfear’s resignation, the Board appointed director Kevin Lalande to the Audit Committee. The Board determined that Mr. Lalande qualifies for Audit Committee membership under Nasdaq listing standards and the independence standard for audit committee members set out in Rule 10A-3 of the Securities and Exchange Act of 1934, as amended.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Molecular Templates, Inc.
Dated: January 17, 2024      
    By:  

/s/ Eric E. Poma, Ph.D.

    Name:   Eric E. Poma, Ph.D.
    Title:   Chief Executive Officer
v3.23.4
Document and Entity Information
Jan. 11, 2024
Cover [Abstract]  
Security Exchange Name NASDAQ
Amendment Flag false
Entity Central Index Key 0001183765
Document Type 8-K
Document Period End Date Jan. 11, 2024
Entity Registrant Name Molecular Templates, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-32979
Entity Tax Identification Number 94-3409596
Entity Address, Address Line One 9301 Amberglen Blvd
Entity Address, Address Line Two Suite 100
Entity Address, City or Town Austin
Entity Address, State or Province TX
Entity Address, Postal Zip Code 78729
City Area Code (512)
Local Phone Number 869-1555
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.001 par value per share
Trading Symbol MTEM
Entity Emerging Growth Company false
Molecular Templates (NASDAQ:MTEM)
Historical Stock Chart
Von Nov 2024 bis Dez 2024 Click Here for more Molecular Templates Charts.
Molecular Templates (NASDAQ:MTEM)
Historical Stock Chart
Von Dez 2023 bis Dez 2024 Click Here for more Molecular Templates Charts.